CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
59.72
0.90 (1.53%)
At close: Aug 15, 2025, 3:59 PM
59.96
0.40%
After-hours: Aug 15, 2025, 07:57 PM EDT
CRISPR Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -208.55M | -136M | -37.31M | -85.94M | -126.41M | -116.59M | 89.35M | -112.15M | -77.74M | -53.06M | -110.58M | -174.55M | -185.83M | -179.22M | -141.25M | -127.15M | 759.23M | -113.16M |
Depreciation & Amortization | 4.6M | 4.74M | 4.84M | 4.74M | 4.84M | 4.83M | 4.9M | 4.92M | 4.96M | 5.05M | 5.85M | 5.02M | 7.27M | 6.04M | 6.26M | 5.32M | 3.65M | 2.71M |
Stock-Based Compensation | 17.61M | 20.21M | 21.95M | 21.54M | 23.67M | 19.41M | 18.42M | 19.97M | 21.77M | 20.88M | 22.8M | 24.55M | 24.85M | 25.75M | 25.77M | 26.2M | 28.33M | 22.09M |
Other Working Capital | -1.81M | 29.85M | 646K | -2.2M | 1.21M | 1.05M | -3.97M | -17.44M | -9.08M | 11.69M | -28.53M | 37.17M | -195K | 5.93M | -10.18M | 9.3M | 13.44M | 239K |
Other Non-Cash Items | 106.58M | 2.25M | -15.15M | -6.9M | 15.9M | -188.76M | -4.77M | -5.16M | -3.15M | -969K | 219K | 2.58M | 3.57M | 6.1M | 4.69M | 5M | 2.35M | 2.06M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -16.51M | 54.85M | -24.35M | -40.36M | 10.49M | 210.49M | -203.97M | 52.56M | -79.08M | 36.91M | -31.62M | 37.19M | 8.19M | 6.09M | 18.49M | 9.3M | 13.44M | -14.37M |
Operating Cash Flow | -113.88M | -53.95M | -50.03M | -106.91M | -95.58M | 109.75M | -96.07M | -39.86M | -133.25M | 8.8M | -113.33M | -105.22M | -141.96M | -135.24M | -86.04M | -81.33M | 807M | -100.66M |
Capital Expenditures | -117K | -206K | -254K | -219K | -707K | -721K | -738K | -2.12M | -3.56M | -3.06M | -6.19M | -6.02M | -9.63M | -15.35M | -9.18M | -37.05M | -28.45M | -7.02M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 80.72M | n/a | n/a | -120.89M | 169.34M | -93.48M | 46.44M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -215.08M | -205.73M | -266.92M | -388.68M | -475.98M | -334.42M | -368.15M | -245.4M | -186.74M | -265.63M | -494.4M | -326.27M | -274M | -323.14M | -122.54M | -670.8M | -392.01M | -323.98M |
Sales Maturities Of Investments | 310.18M | 186.18M | 373M | 247.68M | 349.78M | 237.34M | 287.43M | 369.87M | 408.71M | 386.51M | 325.06M | 419.75M | 227.55M | 223.97M | 123.01M | 142.67M | 126.82M | 163.1M |
Other Investing Acitivies | -25M | n/a | n/a | -20.39M | -126.2M | -7.5M | -80.72M | -1M | -1.5M | 120.89M | -169.34M | 93.48M | -46.44M | -99.17M | 467K | -528.13M | -265.19M | -160.87M |
Investing Cash Flow | 69.98M | -19.75M | 105.83M | -161.6M | -126.91M | -97.8M | -81.45M | 121.35M | 216.92M | 117.83M | -175.53M | 87.46M | -56.07M | -114.52M | -8.72M | -565.18M | -293.64M | -167.9M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9.77M | 11.4M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -466K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | 2.07M | 1.92M | 3.64M | n/a | 25.19M | 6.22M | 1.56M | 16.77M | 5.4M | 2.48M | 14.14M | 10.35M | 10.65M | 6.3M | 10.21M | -1.32M | n/a |
Financial Cash Flow | 2.26M | 10.59M | 16.88M | 9.64M | -466K | 305.93M | 38.94M | 1.56M | 16.77M | 5.4M | 2.48M | 15.11M | 10.35M | 10.65M | 6.3M | 10.21M | 8.44M | 225.99M |
Net Cash Flow | -41.56M | -63.07M | 72.59M | -247.28M | -222.96M | 317.95M | -138.53M | 83M | 100.47M | 132.06M | -286.27M | -2.74M | -187.74M | -239.13M | -88.45M | -636.32M | 521.81M | -42.56M |
Free Cash Flow | -114M | -54.15M | -50.28M | -107.13M | -96.29M | 109.03M | -96.81M | -41.97M | -136.8M | 5.74M | -119.52M | -111.23M | -151.59M | -150.59M | -95.22M | -118.38M | 778.55M | -107.69M |